Psycheceutial Biosciences (BWVI) Listed on WeFunder!

Psycheceutical’s Psychedelic Experience, a Safer More Viable Choice in Getting Treated. Imagine the benefits of psychedelics, without hallucinating!

Cybin (CYBN) Announces Unprecedented Positive Phase 2 Data After Single Dose.

Conference call to discuss CYB003 interim results today, November 1, 2023 at 11:00 a.m. ET

Psychedelics CURED My Alcoholism

RELATED: Matthew Perry Reveals he Spent About $9M Trying to get Sober. Psychedelics CURED...

ClearMind’s (CMND) MEAI and Reducing Alcohol Use.

Amazing New Technologies Keep Popping up. We love when this happens during Sector Bear Markets, which Psychedelics have...

Zappy Zapolin Hopes To Put Ibogaine Front And Center For Addiction

“The only legitimate addiction interrupter capable of breaking a heroin, meth, opiate, or alcohol addiction in a single 12-hour session.”

Adding Cybin (CYBN) $0.46 to 2024 Top Psychedelic Stocks Watch List.

Steve Cohen from Point 72, Acquires 18,950,000 Shares of Cybin.
Zappy Zapolin, Chad Harman, Kevin Harrington, Psychedelic Stock Review

Psycheceutical’s (BWVI) Delivery Tech is Grabbing Attention. Will Pharma Listen?

A startup’s psychedelic delivery tech is grabbing attention. Will pharma listen? PharmaVoice Psycheceutical is developing a back-of-the-neck topical treatment...

COMPASS Pathways (CMPS) Announces Up to $285 Million Private Placement

Transaction led by healthcare specialist investors, TCGX and Aisling Capital $125 million financing upfront with up to...

Billionaire, Point 72’s Steve Cohen, Continues to Support Psychedelic Research.

Cohen Psychedelic Research & Health Initiative Cohen Foundation Awards $5 Million for MDMA Therapy Approval Millions...

Psycheceutical’s (BWVI) NeuroDirect™ Ketamine can Help Alleviate Headaches and Migraines Within Minutes, With no...

Photo MAPS Founder Rick Doblin visits Psycheceutical's Chief Visionary Officer Mike 'Zappy' Zapolin, CEO Chad Harman at the company's lab and tests...

Latest article

Ardelyx (ARDX) Reports First Quarter 2024 Showing $204 Million in Cash!

When we added Ardelyx (ARDX) to the Watch List in November of 2022, the market cap near $80 million. Now it's...

GeoVax to Provide Corporate Update on Tuesday May 14, 2024.

Still our favorite biotech microcap, still our favorite management team, and our favorite risk to reward idea with a $4 million market...

NovaVax (NVAX) Roars Higher, Gaining 225% a $1.2 Billion Increase, at the Blink of...

Sanofi (SNY) Announces Partnership - $500 Million Upfront, plus $700 million in Milestones with NovaVax (NVAX). And some investors say Covid is...